NGM · Biotechnology

Omeros Corporation (OMER) Stock

$19.12 +1.97% NGM: OMER Healthcare

Valuation

MetricValue
Price$19.12
Market Cap$1.38B
P/E Ratio9.82
P/B Ratio-26.34
P/S Ratio35.32
EPS (TTM)$1.29
52-Week High$21.24
52-Week Low$4.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-109.40%
ROA43.52%
ROCE-37.95%
Gross Margin-12.39%
Operating Margin-10.64%
Net Margin324.88%
Debt/Equity-1.63
Current Ratio2.77

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-174.0M$-163.0M$-165.0M$-169.0M$-123.0M
Net Profit$-111.0M$47.0M$-118.0M$-157.0M$-3.0M
EPS$-1.79$0.46$-1.88$-2.70$-0.05
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$419.0M$591.0M$378.0M$277.0M$326.0M
Total Liabilities$395.0M$505.0M$403.0M$460.0M$447.0M
Cash$101.0M$11.0M$7.0M$3.0M$10.0M
Borrowings$348.0M$342.0M$362.0M$207.0M$239.0M

Latest News

AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights Stocktwits · Jul 27, 2026 Omeros (OMER) is Amongst The Best Names Under $10 That Could Yield More Than 200% Return Insider Monkey · Jul 15, 2026 Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? Motley Fool · Jul 8, 2026 Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now? Insider Monkey · Jul 7, 2026 Omeros to Seek EMA Review After Negative Opinion on Narsoplimab Marketing Application MT Newswires · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-110.0M$-86.0M$75.0M$-149.0M$-116.0M
Investing Cash Flow$193.0M$-128.0M$27.0M$82.0M$164.0M
Financing Cash Flow$0$0$-5.0M$104.0M$0
Net Cash Flow$90.0M$-90.0M$-4.0M$-4.0M$6.0M
Free Cash Flow$-110.0M$-87.0M$74.0M$-149.0M$-116.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA10.57
FCF Yield-5.06%
Quick Ratio1.94
Interest Coverage-3.28
Return 1Y169.11%
Return 3Y100.00%
Return 5Y-24.08%

Ownership

Insiders Held3.56%
Institutions Held44.72%
Institutions Float Held46.37%
Institutional HolderSharesReport Date
Blackrock Inc.5,309,6262026-03-31
Ingalls & Snyder LLC3,559,4232026-03-31
Vanguard Capital Management LLC2,983,2592026-03-31
UBS Group AG2,340,7312026-03-31
State Street Corporation1,919,5752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANABAnaptysBio, Inc. $46.21 +1.23% 7.19 $1.37B 0.00%
BHVNBiohaven Ltd. $11.93 +0.42% -2.77 $1.80B 0.00%
CGEMCullinan Therapeutics, Inc. $15.46 -1.09% -4.60 $950.14M 0.00%
CGENCompugen Ltd. $2.12 -1.40% 6.15 $200.45M 0.00%
CRVSCorvus Pharmaceuticals, Inc. $10.21 -1.92% -17.03 $858.56M 0.00%

About Omeros Corporation

Omeros Corporation is led by CEO Gregory A. Demopulos, employs 202 people, headquartered in US, publicly traded since 2009.

Omeros Corporation (OMER) stock trades at $19.12 with a market capitalization of $1.38B. The stock is valued at a price-to-earnings (P/E) ratio of 9.82, price-to-book of -26.34, price-to-sales of 35.32. Over the past 52 weeks the stock has ranged between $4.06 and $21.24, and currently trades 10.0% below its 52-week high.

On profitability, Omeros Corporation generates a return on equity (ROE) of -109.40%, return on capital employed of -37.95%, an operating margin of -10.64%, a net profit margin of 324.88%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides